{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:42:30Z","timestamp":1767177750654,"version":"build-2238731810"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T00:00:00Z","timestamp":1322438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0027887","type":"journal-article","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T17:19:00Z","timestamp":1322500740000},"page":"e27887","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma"],"prefix":"10.1371","volume":"6","author":[{"given":"Zhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiren","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitai","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-6-1","article-title":"Nasopharyngeal carcinoma: molecular biomarker discovery and progress.","volume":"6","author":"WC Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-6-32","article-title":"Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.","volume":"6","author":"W Fang","year":"2008","journal-title":"J Transl Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e19137","DOI":"10.1371\/journal.pone.0019137","article-title":"Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.","volume":"6","author":"ZM Du","year":"2011","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2010.03739.x","article-title":"Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.","volume":"58","author":"S Wang","year":"2011","journal-title":"Histopathology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ijc.25047","article-title":"Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.","volume":"127","author":"HL Lung","year":"2010","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1172\/JCI39374","article-title":"The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.","volume":"119","author":"LB Song","year":"2009","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1371\/journal.pone.0002990","article-title":"OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.","volume":"3","author":"Y Cui","year":"2008","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-1119(99)00234-6","article-title":"Molecular cloning of a novel tissue-specific gene from human nasopharyngeal epithelium.","volume":"237","author":"Z Li","year":"1999","journal-title":"Gene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/ijc.25595","article-title":"Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism.","volume":"128","author":"Z Liu","year":"2011","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ijc.23727","article-title":"Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.","volume":"123","author":"Y Zhou","year":"2008","journal-title":"Int J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e10493","DOI":"10.1371\/journal.pone.0010493","article-title":"REX-1 expression and p38 MAPK activation status can determine proliferation\/differentiation fates in human mesenchymal stem cells.","volume":"5","author":"DR Bhandari","year":"2010","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdermsci.2010.10.009","article-title":"The hsp27kD heat shock protein and p38-MAPK signaling are required for regular epidermal differentiation.","volume":"61","author":"C Jonak","year":"2011","journal-title":"J Dermatol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ijc.11268","article-title":"Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.","volume":"106","author":"LC Jadeski","year":"2003","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/ijc.22393","article-title":"Antitumor activity of ALK1 in pancreatic carcinoma cells.","volume":"120","author":"H Ungefroren","year":"2007","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e11584","DOI":"10.1371\/journal.pone.0011584","article-title":"LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.","volume":"5","author":"B Langlois","year":"2010","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.onc.1205150","article-title":"Hepatocyte growth factor\/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.","volume":"21","author":"JA Recio","year":"2002","journal-title":"Oncogene"},{"key":"ref17","first-page":"183","article-title":"Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.","volume":"29","author":"S Knippen","year":"2009","journal-title":"Anticancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/sj.onc.1203732","article-title":"High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.","volume":"19","author":"V Zoumpourlis","year":"2000","journal-title":"Oncogene"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/carcin\/bgp238","article-title":"MK2 regulates the early stages of skin tumor promotion.","volume":"30","author":"C Johansen","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2004.11.021","article-title":"MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2\/M transition and S phase progression in response to UV irradiation.","volume":"17","author":"IA Manke","year":"2005","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","article-title":"p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage.","volume":"11","author":"HC Reinhardt","year":"2007","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/0008-5472.CAN-09-2918","article-title":"p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.","volume":"70","author":"HC Reinhardt","year":"2010","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-8-147","article-title":"Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR.","volume":"8","author":"R Henkens","year":"2008","journal-title":"BMC Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ncb1398","article-title":"Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence.","volume":"8","author":"S Rahmouni","year":"2006","journal-title":"Nat Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/leu.2010.257","article-title":"Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells.","volume":"25","author":"H Modi","year":"2011","journal-title":"Leukemia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1128\/MCB.00034-09","article-title":"Tyrosine phosphorylation of Grb2: role in prolactin\/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.","volume":"29","author":"E Haines","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ijc.25162","article-title":"miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.","volume":"127","author":"HE Rauhala","year":"2010","journal-title":"Int J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ijc.25161","article-title":"Epigenetic inactivation and tumor suppressor activity of HAI-2\/SPINT2 in gastric cancer.","volume":"127","author":"W Dong","year":"2010","journal-title":"Int J Cancer"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1371\/journal.pone.0002990","article-title":"OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.","volume":"3","author":"Y Cui","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"e9651","DOI":"10.1371\/journal.pone.0009651","article-title":"Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.","volume":"5","author":"GM Poage","year":"2010","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-9-38","article-title":"Elevated expression of CDK4 in lung cancer.","volume":"9","author":"A Wu","year":"2011","journal-title":"J Transl Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1101\/gr.091447.109","article-title":"Genome-wide screen of promoter methylation identifies novel markers in melanoma.","volume":"19","author":"Y Koga","year":"2009","journal-title":"Genome Res"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0233763","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"record-id":"23466"},{"DOI":"10.1371\/journal.pone.0231298","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"record-id":"23115"},{"DOI":"10.1371\/journal.pone.0231298","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0027887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T23:14:06Z","timestamp":1713136446000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0027887"}},"subtitle":[],"editor":[{"given":"Pan-Chyr","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,28]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0027887","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,28]]}}}